Vical hits goals in pandemic vaccine development
Jun 19th, 2009 | By French BioBeach | Category: Latests News and Alerts Forbes – NY,USA
AP , 06.18.09, 10:02 AM EDT SAN DIEGO — Biotechnology company Vical Inc. said Thursday it reached milestones in the development of RapidResponse, …
Posted via email from French BioBeach
Related posts:
- The ALGAEUS: the world’s first algae powered plug-in hybrid vehicle
- Vical’s Vaxfectin(R) Adjuvant Drives 200-Fold Increase in Antibody Responses With Sanofi-Pasteur Fluzone(R) Seasonal Influenza Vaccine
- Sanofi buys into Indian biotech
- French Bio Beach January 26th Event: “Development of Toxicology / Ecotoxicology: New European Regulations, New Business Opportunities”
- US biofuel makers want CO2 credits in climate bill – Reuters
